Haemonetics (HAE) Cash from Investing Activities (2009 - 2026)

Haemonetics' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$86.6 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 580.12% year-over-year to -$86.6 million; the TTM figure through Mar 2026 stood at -$179.5 million (down 10.9% YoY), while the FY2026 annual figure was -$179.5 million, down 10.9% from the prior year.
• Cash from Investing Activities was -$86.6 million for Q1 2026 at Haemonetics, down from -$29.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $18.0 million in Q1 2025 to a low of -$268.9 million in Q4 2023.
• Historically, Cash from Investing Activities has averaged -$47.6 million across 5 years, with a median of -$30.0 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities sank 812.11% in 2024, then surged 238.17% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$36.5 million in 2022, then slumped by 636.81% to -$268.9 million in 2023, then soared by 93.54% to -$17.4 million in 2024, then sank by 69.63% to -$29.5 million in 2025, then sank by 193.94% to -$86.6 million in 2026.
• The last three Cash from Investing Activities figures came in at -$86.6 million (Q1 2026), -$29.5 million (Q4 2025), and -$30.5 million (Q3 2025), per Business Quant data.